Ovarian NeoplasmsNeoplasms, Second PrimaryCystadenomaBrenner TumorGranulosa Cell TumorSertoli-Leydig Cell TumorThecomaCystadenocarcinomaDysgerminomaSertoli Cell TumorOvarian CystsDermoid CystOvarian DiseasesSex Cord-Gonadal Stromal TumorsNeoplasms, Multiple PrimaryCystadenoma, SerousTeratomaHead and Neck NeoplasmsNeoplasm StagingCarcinomaNeoplasms, Radiation-InducedCarcinoma, Squamous CellAdenocarcinomaIsotretinoinImmunohistochemistryNeoplasm Recurrence, LocalLung NeoplasmsSkin NeoplasmsIncidenceNeoplasmsOtorhinolaryngologic NeoplasmsPancreatic NeoplasmsImmunoproliferative DisordersRadiotherapyRisk FactorsFollow-Up StudiesBreast NeoplasmsNervous System NeoplasmsTooth ExfoliationLaryngeal NeoplasmsEye NeoplasmsOropharyngeal NeoplasmsMouth NeoplasmsSurvivorsRiskRetrospective StudiesThyroid NeoplasmsRegistriesNeoplasms, Cystic, Mucinous, and SerousSEER ProgramRetinoblastomaChromium CompoundsKidney NeoplasmsSurvival RatePharyngeal NeoplasmsHypopharyngeal NeoplasmsTime FactorsNeoplasm MetastasisProportional Hazards ModelsPrognosisSurvival AnalysisHodgkin DiseaseAge FactorsSmokingTooth, DeciduousAnticarcinogenic AgentsCombined Modality TherapyCohort StudiesMelanomaGenes, p53QueenslandDisease-Free SurvivalMaintenance ChemotherapyStomach NeoplasmsCarcinoma, Basal CellCase-Control StudiesColonic NeoplasmsPneumonectomyLoss of HeterozygosityRisk AssessmentTreatment OutcomeNeoplasms, Squamous CellColorectal NeoplasmsAdenocarcinoma, MucinousEsophageal NeoplasmsCarcinoma, Small CellMyeloproliferative DisordersTomography, X-Ray ComputedNuclear WarfareActuarial AnalysisTumor Markers, BiologicalLymphoma, Non-HodgkinMolarDNA, NeoplasmParotid NeoplasmsGenetic Predisposition to DiseasePoisson DistributionDose FractionationNeoplasms, Connective and Soft TissuePrecancerous Conditions